淋巴血管栓塞内的瘤休眠受多种代谢信号通路的调节
Yin Ye1, Justin Wang2, Jordan Dillard1
1Department of Pathology, Anatomy and Cell Biology and the Clinical and Translational Research Center of Excellence, Meharry Medical College, Nashville, TN, U.S.A.
淋巴血管栓塞中癌细胞休眠状态是由特定的代谢和信号通路维持的. 破坏这些通路,特别是PI3K/Akt,可以导致癌细胞死亡,提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 细胞的新陈代谢
背景情况:
- 癌症休眠期是在淋巴血管瘤栓塞中启动的,其特点是减少了拉巴胺素 (mTOR) 活性的扩散和哺乳动物点.
- 研究交叉的新陈代谢信号通路对于了解休眠栓塞的命运至关重要.
研究的目的:
- 研究信号通路 (AMPK,mTOR,PI3K/Akt) 以及它们在维持或破坏瘤栓塞内癌症休眠状态中的作用.
- 确定卡尔巴因介导的E-cadherin蛋白解对球形状的形成和休眠的贡献.
主要方法:
- 使用患者衍生异种移植 (PDX) 模型的炎症性乳腺癌 (玛丽-X) 在体外形成球体 (栓塞等效).
- 检查了途径抑制剂 (拉帕米辛,LY294002,C化合物) 和营养物质可用性 (无血清介质) 对球状体行为和信号的影响.
主要成果:
- 减少酸化AMPK与球形形成相关.
- 单独抑制mTOR并没有破坏休眠状态;然而,PI3K/Akt抑制诱导了亡和球状失粘性.
- 抑制AMPK促进了球状脱和亡,而细胞代谢的增加导致了细胞死亡.
- 在无血清条件下保持休眠状态,表明对饥饿诱导的mTOR抑制的抵抗力.
结论:
- 了解内部信号通路,可以了解调节癌症休眠期的外部刺激 (如饥饿,缺氧).
- 针对特定的代谢和信号通路,如PI3K/Akt,可能提供克服癌症休眠和预防转移的策略.
更多相关视频
09:14An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
相关概念视频
The Tumor Microenvironment
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
